1-9 of 9
Steinar Lundgren
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P6-10-04: Homologous recombination deficiency across subtypes of primary breast cancer

Christina Engebrethsen, Synnøve Yndestad, Andrea Herencia-Ropero, Oleksii Nikolaienko, Olav Karsten Vintermyr, Reidun K. Lillestøl, Laura Minsaas, Beryl Leirvaag, Gjertrud Iversen, Bjørnar Gilje, Egil Blix, Helge Espelid, Steinar Lundgren, Jürgen Geisler, Liv Jorunn Vassbotn, Hildegunn S. Aase, Turid Aas, Alba Llop-Guevara, Violeta Serra, Per Eystein Lønning, Stian Knappskog, Hans Petter Eikesdal
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P6-10-04.
https://doi.org/10.1158/1538-7445.SABCS22-P6-10-04
Published: 01 March 2023
View article titled, Abstract P6-10-04: Homologous recombination deficiency across subtypes of primary breast cancer
Journal Articles

Abstract P1-13-01: Lipoprotein and metabolite responses to physical exercise during adjuvant breast cancer treatment

Torfinn Støve Madssen, Vidar Gordon Flote, Inger Thune, Gro Falkener Bertheussen, Anders Husøy, Steinar Lundgren, Hanne Frydenberg, Erik Wist, Ellen Schlichting, Jon Lømo, Anne McTiernan, Tone Frost Bathen, Guro Fanneløb Giskeødegård
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P1-13-01.
https://doi.org/10.1158/1538-7445.SABCS19-P1-13-01
Published: 15 February 2020
View article titled, Abstract P1-13-01: Lipoprotein and metabolite responses to physical exercise during adjuvant breast cancer treatment
Journal Articles

Abstract 1813: Bevacizumab potentiates the proteomic response to neoadjuvant chemotherapy in breast cancer patients: Rppa exploration of consecutive tumor samples in the NeoAva randomized phase II trial

Mads H. Haugen, Ole Christian Lingjaerde, Marit Krohn, Wei Zhao, Evita M. Lindholm, Laxmi Silwal-Pandit, Elin Borgen, Øystein Garred, Anne Fangberget, Marit M. Holmen, Ellen Schlichting, Helle K. Skjerven, Steinar Lundgren, Erik Wist, Bjørn Naume, Gunhild M. Maelandsmo, Yiling Lu, Anne-Lise Boerresen-Dale, Gordon B. Mills, Olav Engebraaten
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 1813.
https://doi.org/10.1158/1538-7445.AM2017-1813
Published: 01 July 2017
View article titled, Abstract 1813: Bevacizumab potentiates the proteomic response to neoadjuvant chemotherapy in breast cancer patients: Rppa exploration of consecutive tumor samples in the NeoAva randomized phase II trial
Journal Articles

Abstract 3268: Proteomic response in breast cancer treated with neoadjuvant chemotherapy with and without bevacizumab: Reverse phase protein array (RPPA) results from NeoAva - a randomized phase II study

Mads H. Haugen, Ole Christian Lingjaerde, Marit Krohn, Evita M. Lindholm, Laxmi Silwal-Pandit, Elin Borgen, Øystein Garred, Anne Fangberget, Marit M. Holmen, Ellen Schlichting, Helle Skjerven, Steinar Lundgren, Erik Wist, Bjoern Naume, Gunhild M. Maelandsmo, Yiling Lu, Anne-Lise Boerresen-Dale, Gordon B. Mills, Olav Engebraaten
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3268.
https://doi.org/10.1158/1538-7445.AM2016-3268
Published: 15 July 2016
View article titled, Abstract 3268: Proteomic response in breast cancer treated with neoadjuvant chemotherapy with and without bevacizumab: Reverse phase protein array (RPPA) results from NeoAva - a randomized phase II study
Journal Articles

Abstract 3925: Crown-like structures and adipocyte size in fat tissue adjacent to breast tumor reflect parameters of obesity, dyslipidemia and serum high-sensitivity C-reactive protein

Charlotte Vaysse, Inger Thune, Øystein Garred, Catherine Muller, Ellen Schlichting, Frøydis Fjeldheim, Anne McTiernan, Hanne Frydenberg, Anders Husøy, Steinar Lundgren, Morten W Fagerland, Erik A Wist, Jon Lømo
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3925.
https://doi.org/10.1158/1538-7445.AM2016-3925
Published: 15 July 2016
View article titled, Abstract 3925: Crown-like structures and adipocyte size in fat tissue adjacent to breast tumor reflect parameters of obesity, dyslipidemia and serum high-sensitivity C-reactive protein
Journal Articles

Abstract P4-11-14: Molecular response in breast cancer treated with neoadjuvant chemotherapy with and without bevacizumab: Results from NeoAva - a randomized phase II study

Olav Engebraaten, Laxmi Silwal-Pandit, Marit Krohn, Elen K Møller, Silje Nord, Thomas Fleischer, Hedda von der Lippe Gythfelt, Elin Borgen, Øystein Garred, Anne Fangberget, Marit Muri Holmen, Ellen Schlichting, Helle Skjerven, Steinar Lundgren, Vessela N Kristensen, Ole Christian Lingjaerde, Erik Wist, Bjørn Naume, Anne-Lise Børresen-Dale
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-11-14.
https://doi.org/10.1158/1538-7445.SABCS14-P4-11-14
Published: 01 May 2015
View article titled, Abstract P4-11-14: Molecular response in breast cancer treated with neoadjuvant chemotherapy with and without bevacizumab: Results from NeoAva - a randomized phase II study
Journal Articles

Abstract 1533: A time course study of genomic instability in breast cancer patients receiving neoadjuvant therapy with or without bevacizumab

Elen K. Møller, Silje Nord, Hans Kristian Moen Vollan, Hedda von der Lippe Gythfeldt, Hege Edvardsen, Laxmi Silwal- Pandit, Marit Krohn, Thomas Fleischer, Ellen Schlitchting, Elin Borgen, Øystein Garred, Anne Fangberget, Marit M. Holmen, Helle Skjerven, Steinar Lundgren, Erik Wist, Bjørn Naume, Anne-Lise Børresen-Dale, Ole Christian Lingjærde, Olav Engebråten, Vessela N. Kristensen
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1533.
https://doi.org/10.1158/1538-7445.AM2014-1533
Published: 01 October 2014
View article titled, Abstract 1533: A time course study of genomic instability in breast cancer patients receiving neoadjuvant therapy with or without bevacizumab
Journal Articles

Abstract P5-17-02: Molecular response in breast cancer tumors treated with neoadjuvant chemotherapy with and without bevacizumab: Results from NeoAva - a randomized phase II study.

Olav Engebraaten, Laxmi Silwal-Pandit, Thomas Fleischer, Elin Borgen, Øystein Garred, Anne Fangberget, Marit M Holmen, Ellen Schlichting, Helle Skjerven, Steinar Lundgren, Ingrid S Gribbestad, Marit Krohn, Hege Edvardsen, Vessela N Kristensen, Gordon Mills, Erik Wist, Anne-Lise Børresen-Dale
Journal: Cancer Research
Cancer Res (2012) 72 (24_Supplement): P5-17-02.
https://doi.org/10.1158/0008-5472.SABCS12-P5-17-02
Published: 15 December 2012
View article titled, Abstract P5-17-02: Molecular response in breast cancer tumors treated with neoadjuvant chemotherapy with and without bevacizumab: Results from NeoAva - a randomized phase II study.
Journal Articles

Distribution of 4-Hydroxy-N-desmethyltamoxifen and Other Tamoxifen Metabolites in Human Biological Fluids during Tamoxifen Treatment

Ernst A. Lien, Einar Solheim, Oscar A. Lea, Steinar Lundgren, Stener Kvinnsland, Per M. Ueland
Journal: Cancer Research
Cancer Res (1989) 49 (8): 2175–2183.
Published: 01 April 1989
View article titled, Distribution of 4-Hydroxy-<em>N</em>-desmethyltamoxifen and Other Tamoxifen Metabolites in Human Biological Fluids during Tamoxifen Treatment
Open the PDF for Distribution of 4-Hydroxy-<em>N</em>-desmethyltamoxifen and Other Tamoxifen Metabolites in Human Biological Fluids during Tamoxifen Treatment in another window